About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer ...
The report highlights opportunities in optimizing clinical trial strategies for gastric cancer by identifying key global locations, understanding enrollment trends, and analyzing trial success rates.
About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer ...
CAMBRIDGE, Mass., April 23, 2025 /PRNewswire/ -- Nuvalent, Inc. (NUVL) (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven ...
90 mg once-daily palazestrant dose selected for Part 2 of the Phase 3 OPERA-01 monotherapy trial and for the Phase 3 OPERA-02 combination trial with ribociclib OPERA-01 trial-in-progress poster to be ...
New AACR data highlight stenoparib’s potential in colorectal cancer through WNT pathway modulationThe Stenoparib-DRP® companion ...
City of Hope, which earlier this month opened a new hospital in Orange County, Calif., (shown in this picture) now has a network of five specialized cancer hospitals across the country and 38 clinical ...
The LSU LCMC Health Cancer Center has strategically expanded its Cancer Clinical Trials Office, reinforcing its commitment to ...
Donna Gustafson had a harder time than usual shaking off the jet lag from her 22-hour journey from Florida to Australia. Two days into her trip, her skin took on the yellow hue of jaundice. Subscribe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results